Last reviewed · How we verify

NCT04245163

Development and Implementation of an Educational Program to Enhance Adherence to Glaucoma Treatment

Status unknown NA Last updated 10 March 2021
What this trial tests

NA trial testing Educational program in Glaucoma in 40 participants. Status unknown.

Timeline
10 June 2021
Primary endpoint
10 July 2021
1 September 2021

Quick facts

Lead sponsorCyprus University of Technology
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment40
Start date10 June 2021
Primary completion10 July 2021
Estimated completion1 September 2021
Sites1 location across Cyprus

Drugs / interventions tested

Conditions studied

Sponsor

Cyprus University of Technology

Who can join

18 and older, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the addition of an educational intervention program in order to improve medication adherence in glaucoma patients. Half of the participants will receive the educational program while the other half will receive normal care and a leaflet about glaucoma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Educational program

Trials testing the same drug.

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

Other Cyprus University of Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04245163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing